miR-766-3p Targeting BCL9L Suppressed Tumorigenesis, Epithelial-Mesenchymal Transition, and Metastasis Through the β-Catenin Signaling Pathway in Osteosarcoma Cells-Reference-Cited by-同舟云学术

miR-766-3p Targeting BCL9L Suppressed Tumorigenesis, Epithelial-Mesenchymal Transition, and Metastasis Through the β-Catenin Signaling Pathway in Osteosarcoma Cells

Published:2020-10-07 Issue: Volume:8 Page:
ISSN:2296-634X
Container-title:Frontiers in Cell and Developmental Biology
language:
Short-container-title:Front. Cell Dev. Biol.

Author:

Zhang Sheng,Chen Hongtao,Liu Wanshun,Fang Le,Qian Zhanyang,Kong Renyi,Zhang Qi,Li Juming,Cao Xiaojian

Funder

National Natural Science Foundation of China

Publisher

Frontiers Media SA

Subject

Cell Biology,Developmental Biology

Reference49 articles.

1. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.;Adachi;Cancer Res.,2004

2. Osteosarcoma in adolescents and adults: survival analysis with and without lung metastases.;Aljubran;Ann. Oncol.,2009

3. Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.;Allen-Rhoades;Cancer Med.,2015

4. MicroRNAome genome: a treasure for cancer diagnosis and therapy.;Berindan-Neagoe;CA Cancer J. Clin.,2014

5. EMT in cancer.;Brabletz;Nat. Rev. Cancer,2018

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment;International Immunopharmacology;2024-03

2. Corrigendum: miR-766-3p targeting BCL9L suppressed tumorigenesis, epithelial-mesenchymal transition, and metastasis through the β-catenin signaling pathway in osteosarcoma cells;Frontiers in Cell and Developmental Biology;2023-11-15

3. MiR-766-3p and miR-671-5p attenuate aristolochic acid-induced hepatotoxicity by directly targeting the key bioactivating enzyme NQO1;Ecotoxicology and Environmental Safety;2023-08

4. Clostridium butyricum inhibits epithelial–mesenchymal transition of intestinal carcinogenesis through downregulating METTL3;Cancer Science;2023-05-26

5. The key role of microRNA-766 in the cancer development;Frontiers in Oncology;2023-05-02